Heritage Cannabis - CEO, David Schwede.
CEO, David Schwede.
Source: Heritage Cannabis.
  • Heritage Cannabis (CANN) has entered an agreement with West Virginia’s Harvest Care Medical
  • The company will supply production equipment and training to Harvest Care in exchange for favorable shelf allocation in its West Virginia dispensaries
  • Harvest Care’s cultivation license will also allow Heritage to produce branded products for medical cannabis consumers in the state
  • Heritage Cannabis Holdings offers innovative cannabis products to the medical and recreational markets in Canada and the U.S.
  • Heritage (CANN) is up by 14.29 per cent trading at $0.04 per share

Heritage Cannabis (CANN) has entered an agreement with West Virginia’s Harvest Care Medical.

Harvest Care is a leading grower, processor and provider of medical cannabis products with ten dispensary licenses in West Virginia, of which two are in operation.

Heritage will supply production equipment to Harvest Care, as well as training and supervision of staff, in exchange for favorable shelf allocation in Harvest Care’s West Virginia dispensaries. Heritage expects the production equipment to be operational by September.

Harvest Care was also granted one of ten cultivation licenses last year, allowing Heritage to produce branded products for medical cannabis consumers in the state.

According to MJBiz, total cannabis sales in West Virginia are expected to grow to US$40 million by 2025.

“We believe that in an early-stage, lower-competition market like West Virginia, we can successfully bring Heritage’s branded offerings to this growing market and see vast upside potential in our expansion strategy and its positive impact on profitability,” said David Schwede, Heritage’s CEO.

Heritage Cannabis Holdings offers innovative cannabis products to the medical and recreational markets in Canada and the U.S. Brands include Purefarma, Pura Vida, RAD, Premium 5, feelgood, CB4 and ArthroCBD.

Heritage (CANN) is up by 14.29 per cent trading at $0.04 per share as of 11:23 am EST.


More From The Market Online

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

The Market Online’s Weekly Cannabis Report – May 10, 2024

A leading North American cannabis and consumer packaged goods company will acquire key players in its U.S. expansion strategy.

Canopy Growth prepares for U.S. expansion with new acquisitions

Canopy Growth (TSX:WEED) exercises its options to acquire Wana and Jetty Extracts, key players in the company's U.S. expansion strategy.